Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases

17 Oct 2017

Abstract excerpt

Fibrotic diseases are characterized by net accumulation of extracellular matrix proteins in affected organs leading to their dysfunction and ultimate failure. Myofibroblasts have been identified as the cells responsible for the progression of the fibrotic process, and they originate from several sources, including quiescent tissue fibroblasts, circulating CD34⁺ fibrocytes and the phenotypic conversion of various...

Topics

Join the communities discussing this publication.

Cardiac Fibrosis and Remodeling
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Occupational and environmental lung diseases

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 29039786
DOI: 10.3390/ijms18102157

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic DiseasesPMID 29039786Read ↗

TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue EngineeringSemantic proximity Read ↗

Roles of TGF-<i>β</i>Signals in Endothelial-Mesenchymal Transition during Cardiac FibrosisSemantic proximity Read ↗

Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic DiseasesSemantic proximity Read ↗

Emerging roles of inflammation-mediated endothelial–mesenchymal transition in health and diseaseSemantic proximity Read ↗

Experimental Models to Study Endothelial to Mesenchymal Transition in Myocardial Fibrosis and Cardiovascular DiseasesSemantic proximity Read ↗

Molecular mechanisms of endothelial to mesenchymal cell transition (EndoMT) in experimentally induced fibrotic diseasesSemantic proximity Read ↗

Fine‐tuning vascular fate during endothelial–mesenchymal transitionSemantic proximity Read ↗

TGFβ Signaling and Cardiovascular DiseasesSemantic proximity Read ↗

Endothelial-Mesenchymal Transition in Cardiovascular Disease.Semantic proximity Read ↗

The role of endothelial–mesenchymal transition in development and pathological processSemantic proximity Read ↗

Endothelial to Mesenchymal Transition in the Cardiogenesis and Cardiovascular DiseasesSemantic proximity Read ↗

TGFβ signaling and the control of myofibroblast differentiation: Implications for chronic inflammatory disorders.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.